MedPath

Fluvoxamine Maleate

These highlights do not include all the information needed to use FLUVOXAMINE MALEATE TABLETS safely and effectively. See full prescribing information for FLUVOXAMINE MALEATE TABLETS. FLUVOXAMINE MALEATE tablets, for oral use Initial U.S. Approval: 1994

Approved
Approval ID

47daea9e-545d-4a67-b2b2-d12c3c98734b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 14, 2022

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluvoxamine Maleate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-1974
Application NumberANDA075902
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fluvoxamine Maleate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 30, 2021
FDA Product Classification

INGREDIENTS (7)

TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)Inactive
Code: 8136Y38GY5
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FLUVOXAMINE MALEATEActive
Quantity: 50 mg in 1 1
Code: 5LGN83G74V
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.